NCT03897010 is a Phase 4 clinical trial of Socket Graft in Ridge Deficiency, sponsored by Ain Shams University.

Who is sponsoring NCT03897010?

NCT03897010 is sponsored by Ain Shams University.

What drugs are being tested in NCT03897010?

Interventions in NCT03897010: Socket Graft.

What condition does NCT03897010 study?

NCT03897010 studies Ridge Deficiency.

Is NCT03897010 still recruiting?

NCT03897010 is currently completed. Last updated 2 April 2019.

Last reviewed 2019-04-02 · How we verify

NCT03897010

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Silica-calcium Phosphate Composite in Socket Augmentation

Completed Phase 4 Last updated 2 April 2019

What this trial tests

Phase 4 trial testing Socket Graft in Ridge Deficiency in 5 participants. Completed in 15 February 2019.

Timeline

20 November 2017

Primary endpoint
1 February 2019

15 February 2019

Quick facts

Lead sponsor	Ain Shams University
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	5
Start date	20 November 2017
Primary completion	1 February 2019
Estimated completion	15 February 2019
Sites	1 location across Egypt

Drugs / interventions tested

Socket Graft

Conditions studied

Ridge Deficiency — all drugs for Ridge Deficiency →

Sponsor

Ain Shams University

Who can join

Adults 20 to 45, any sex, with Ridge Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ideal bone graft should possess osteogenic, osteoinductive, and osteoconductive properties. Unfortunately, all of these are solely found within the autogenous graft that is available only in limited quantities, and it is associated with substantial post-surgical morbidity, However in this study Silica-calcium phosphate composite (SCPC) confirmed clinically, radiographically, histomorphometricand immunohistochemically the vitality and functionality of the newly formed bone. Histology and immunohistochemistry demonstrated maturation of the newly formed bone as indicated by presence of osteocytes, Haversian systems, blood vessels, compact mineralized collagen type I and high immune staining for osteopontin.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Bone regeneration and graft material resorption in extraction sockets grafted with bioactive silica-calcium phosphate composite (SCPC) versus non-grafted sockets: clinical, radiographic, and histological findings.
Adel-Khattab D, Afifi NS, Abu El Sadat SM, Aboul-Fotouh MN, et al · · 2020 · cited 9× · PMID 33350181 · DOI 10.5051/jpis.2000040002

Verify or expand the search:

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03897010 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 2 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03897010.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing